Brief: TherapeuticsMD Says Net Loss For Q2 2021 Was $0.11 Per Basic And Diluted Share

TherapeuticsMD

04/08/2021 11:58

Aug 4 (Reuters) - TherapeuticsMD Inc  TXMD.O :
    * THERAPEUTICSMD ANNOUNCES SECOND QUARTER 2021 FINANCIAL
RESULTS
    * THERAPEUTICSMD INC - 2Q21 TOTAL NET PRODUCT REVENUE
INCREASED BY
17% OVER 1Q21 TO $23 MILLION
    * THERAPEUTICSMD INC - NET LOSS FOR Q2 2021 WAS $0.11 PER
BASIC
AND DILUTED SHARE
    * THERAPEUTICSMD INC - AS OF JUNE 30, 2021, COMPANY'S CASH
ON HAND
TOTALED $111.4 MILLION, COMPARED WITH $80.5 MILLION AS OF
DECEMBER 31, 2020

Source text for Eikon:  ID:nBwb9Ydqna 
Further company coverage:  TXMD.O 

 ((reuters.briefs@thomsonreuters.com;))